NCT07174388Recruiting
An External Control Arm Study in Non-Small Cell Lung Cancer
A Prospective Study to Generate Precision External Controls in Advanced or Metastatic Non Small Cell Lung Cancer Patients
Source: ClinicalTrials.gov · Last updated 22 Sept 2026
Brief summary (registry, in English)
A study to create control arms using current and future information in patients with lung cancer.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 650 (estimated)
- First submitted
- 12 Sept 2025
- Start date
- 7 Jan 2026
- Primary completion date
- Apr 2029
- Lead sponsor
- N-Power Medicine
- Diseases
- Lung cancer
- NCT number
- NCT07174388
What you commit to
- Study type: Observational
- Planned participants: 650
- From 7 Jan 2026 to the primary completion date, Apr 2029
- 11 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Actively on a clinical trial of an investigational agent
- Currently receiving active systemic therapy for another malignancy
- Eligible for treatment with curative intent
- \*see protocol for cohort specific exclusion criteria\*
Who the study is looking for
- \> 18 years of age at the time of informed consent
- Pathologically confirmed locally advanced or metastatic NSCLC
- ECOG Performance of less than or equal to 1 within 4 weeks prior to starting index therapy.
- Life expectancy of more than 3 months
- Able to understand and sign informed consent
- Evidence of measurable disease (as assessed by the Investigator) on available imaging (e.g CT, MRI, PET)
- \*see protocol for cohort specific inclusion criteria\*
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (11)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| New Mexico Oncology Hematology Consultants Coordinator of this site? Confirm its status | Albuquerque | United States | Recruiting |
| Northwest Oncology and Hematology Coordinator of this site? Confirm its status | Barrington | United States | Recruiting |
| Bayhealth Medical Center, Kent Campus Coordinator of this site? Confirm its status | Dover | United States | Recruiting |
| Northwest Oncology and Hematology Coordinator of this site? Confirm its status | Elk Grove | United States | Recruiting |
| Northwest Oncology and Hematology Coordinator of this site? Confirm its status | Hoffman Estates | United States | Recruiting |
| Oncology Consultants Coordinator of this site? Confirm its status | Houston | United States | Recruiting |
| Bayhealth Medical Center- Sussex Campus Coordinator of this site? Confirm its status | Milford | United States | Recruiting |
| Pacific Cancer Care Coordinator of this site? Confirm its status | Monterey | United States | Recruiting |
| New York Cancer and Blood Specialists Coordinator of this site? Confirm its status | New York | United States | Recruiting |
| Northwest Oncology and Hematology Coordinator of this site? Confirm its status | Rolling Meadows | United States | Recruiting |
| Main Line Health Coordinator of this site? Confirm its status | Wynnewood | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.